These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1084897

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Suppressor T cells regulate the cytolytic T lymphocyte response to syngeneic tumors induced by murine sarcoma virus (MSV) in the mouse.
    Plata F, MacDonald HR, Shain B.
    J Immunol; 1979 Aug; 123(2):852-60. PubMed ID: 156765
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA, Shu S, Chou T, Perry-Lalley D, Chang AE.
    J Immunol; 1988 Aug 01; 141(3):1047-53. PubMed ID: 3260908
    [Abstract] [Full Text] [Related]

  • 6. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F, Jongeneel CV.
    J Immunol; 1977 Aug 01; 119(2):623-9. PubMed ID: 196025
    [No Abstract] [Full Text] [Related]

  • 7. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
    Evans R, Duffy T.
    J Immunol; 1985 Jun 01; 134(6):4255-60. PubMed ID: 3872913
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
    Landolfo S, Herberman RB, Holden HT.
    J Immunol; 1977 Apr 01; 118(4):1244-8. PubMed ID: 191532
    [Abstract] [Full Text] [Related]

  • 9. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
    Plata F, Gomard E, Leclerc JC, Levy JP.
    J Immunol; 1974 Apr 01; 112(4):1477-87. PubMed ID: 4360862
    [No Abstract] [Full Text] [Related]

  • 10. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.
    Zanovello P, Vallerani E, Biasi G, Landolfo S, Collavo D.
    J Immunol; 1988 Feb 15; 140(4):1341-4. PubMed ID: 2830339
    [Abstract] [Full Text] [Related]

  • 11. T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo.
    Leclerc JC, Cantor H.
    J Immunol; 1980 Feb 15; 124(2):851-4. PubMed ID: 6243333
    [Abstract] [Full Text] [Related]

  • 12. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.
    Tsung K, Dolan JP, Tsung YL, Norton JA.
    Cancer Res; 2002 Sep 01; 62(17):5069-75. PubMed ID: 12208763
    [Abstract] [Full Text] [Related]

  • 13. Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.
    Gorczynski RM.
    J Immunol; 1974 May 01; 112(5):1826-38. PubMed ID: 4361978
    [No Abstract] [Full Text] [Related]

  • 14. Host responses with solid tumors. I. Monocytic effector cells within rat sarcomas.
    Haskill JS, Proctor JW, Yamamura Y.
    J Natl Cancer Inst; 1975 Feb 01; 54(2):387-93. PubMed ID: 1113322
    [Abstract] [Full Text] [Related]

  • 15. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
    Yoshizawa H, Chang AE, Shu SY.
    Cancer Res; 1992 Mar 01; 52(5):1129-36. PubMed ID: 1531321
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA, Macphail S, Bach FH, Zarling JM.
    J Immunol; 1980 Jul 01; 125(1):36-9. PubMed ID: 6155401
    [Abstract] [Full Text] [Related]

  • 18. Cooperation of immune lymphoid and reticuloendothelial cells during Listeria monocytogenes-mediated tumor immunity.
    Youdim.
    Cancer Res; 1977 Apr 01; 37(4):991-6. PubMed ID: 403003
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Further evidence for the involvement of thymus-processed lymphocytes in syngeneic tumor cell cytolysis.
    Plata F, Gomard E, Leclerc JC, Levy JP.
    J Immunol; 1973 Sep 01; 111(3):667-71. PubMed ID: 4542607
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.